[Ip-health] Question re: legal tests for 'reasonable' or 'excessive' pricing

Jamie Love james.love at keionline.org
Tue Nov 8 06:19:11 PST 2016


I recommend reviewing these reports and evalutions in the 2002/2003 Hazel
Tau case (from many experts) : http://keionline.org/node/2074

And my statement in the Nexavar case: http://keionline.org/node/1359



On Tue, Nov 8, 2016 at 6:13 AM, Suerie Moon <suerie_moon at yahoo.com> wrote:

> Dear ip-health readers,
> Could somebody point me to any legal tests/approaches to determining what
> is a 'reasonable' vs 'excessive' price for a product? I am particularly
> looking for any tests related to medicines, but application of the
> principle to non-medical products would also be of interest.
> Thanks in advance,Suerie Moon
> _____________________________
>
> Suerie Moon, MPA, PhD
> Director of Research, Global Health Centre and Visiting Lecturer,
> GraduateInstitute of International and Development Studies, Geneva
> Adjunct Lecturer, Department of Global Health and Population, Harvard T.H.
> ChanSchool of Public Health
> suerie.moon at graduateinstitute.ch
> tel: +41-22-908-5845
>
> _______________________________________________
> Ip-health mailing list
> Ip-health at lists.keionline.org
> http://lists.keionline.org/mailman/listinfo/ip-health_lists.keionline.org
>



-- 
James Love.  Knowledge Ecology International
http://www.keionline.org/donate.html
KEI DC tel: +1.202.332.2670, US Mobile: +1.202.361.3040, Geneva Mobile:
+41.76.413.6584, twitter.com/jamie_love



More information about the Ip-health mailing list